Lansdowne Partners is a European headquartered investment manager operating a diversified range of actively managed equity strategies.
Portfolio
6
companies
AttoCore
AttoCore develops scalable and flexible 4G and 5G core network solutions.
MoA Technology
MoA Technology develops next-generation herbicides to combat global weed resistance.
Osler Diagnostics
Osler Diagnostics develops portable tabletop blood-testing devices for clinical and decentralized settings.
Oxford Ionics
Oxford Ionics builds high-performance quantum computers using trapped-ion technology.
Oxford Quantum Circuits
Oxford Quantum Circuits develops advanced quantum computing hardware using patented 3D architecture.
Papier
Papier designs and sells personalised stationery products through an online platform.
Peter Davies
Partner & Head of Developed Markets Strategy
Peter brings fund management experience from Lansdowne Partners and Mercury Asset Management. He currently serves as partner and head of developed markets strategy at Lansdowne Partners.
LinkedInThe Series C round was co-led by Oxford Science Enterprises and Supernova Invest to support product development.
"When we helped spin Moa out from the University of Oxford’s Plant Sciences Department in 2017, we saw that its technology platform had a unique and important approach to address the market’s need for herbicides capable of breaking weed resistance,"
SBI Investment led the Series B round to support the international rollout of OQC quantum platforms.
"To solve the world's most pressing challenges – from climate change to accelerated drug discovery – we need to put quantum computers in the hands of humanity and at the fingertips of our most brilliant minds. We're proud to be pioneering enterprise ready quantum with our customers, partners and investors."
The Series A round was led by Oxford Science Enterprises and Braavos Investment Advisers to support company expansion.
"Through its unique approach, developed by some of the world’s best minds in the quantum space, Oxford Ionics is laying the foundations to finally make quantum computing a scalable, integrable and viable option. Building on more than a decade at the forefront of this sector, Chris, Tom and the team have been able to demonstrate, time and again, that their work in the lab can, and will, extend to the real world and we’re thrilled to be joining them on this journey."
The round was backed by M&G Investments alongside existing supporters Oxford Science Enterprises, Braavos Investment Advisers, and Lansdowne Partners.
"The Osler Origin platform has the potential to transform healthcare by enabling anyone, anywhere, to access, understand, and act on their healthcare information. This new investment allows us to advance the Osler Origin towards market, and to realise our vision."
The financing was co-led by Lansdowne Partners and The University of Tokyo Edge Capital Partners.
"Quantum computing promises to be the next frontier of innovation, and OQC, with its state-of-the-art Coaxmon technology, aims to integrate the forefront of modern physics into our everyday lives. UTEC is honoured to be part of OQC’s mission of making quantum technology accessible to all and will support OQC’s expansion into Asia-Pacific through collaborations with academia including the University of Tokyo, and partnerships with Japan’s leading financial and tech corporations."
